17 alpha-hydroxyprogesterone caproate has been researched along with Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Amaral, LM; Comley, KM; Cottrell, JN; Cunningham, MW; Ibrahim, T; LaMarca, B; Vaka, VR; Witcher, A | 1 |
| Rascati, KL; Zhang, S | 1 |
| Kiprono, LV; Lamarca, B; Martin, J; Moseley, J; Wallace, K | 1 |
3 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Hypertension
| Article | Year |
|---|---|
17-Hydroxyprogesterone caproate improves hypertension and renal endothelin-1 in response to sFlt-1 induced hypertension in pregnant rats.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Blood Pressure; Endothelin-1; Female; Humans; Hypertension; Kidney; Pregnancy; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2020 |
Utilization, adherence, and outcomes of 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hypertension; Infant, Newborn; Injections, Intramuscular; Pregnancy; Premature Birth; United States | 2021 |
Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Disease Models, Animal; Endothelial Cells; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxyprogesterones; Hypertension; Ischemia; Placenta; Placental Circulation; Pre-Eclampsia; Pregnancy; Progesterone; Progestins; Rats; Rats, Sprague-Dawley | 2013 |